Cureteq AG
Cureteq uses artificial intelligence to identify promising drug assets and accelerate their development. It operates as an asset management and biotechnology company with an AI platform that evaluates molecules and guides clinical development. The model combines portfolio management with hands-on expertise to advance assets toward clinically meaningful inflection points. Category and tech: B2B biotech and drug development powered by AI, with partnerships like Innoplexus. Founded in 2021, Cureteq targets biotech firms and pharmaceutical companies seeking to de-risk programs at scale.
Cureteq AG
Cureteq uses artificial intelligence to identify promising drug assets and accelerate their development. It operates as an asset management and biotechnology company with an AI platform that evaluates molecules and guides clinical development. The model combines portfolio management with hands-on expertise to advance assets toward clinically meaningful inflection points. Category and tech: B2B biotech and drug development powered by AI, with partnerships like Innoplexus. Founded in 2021, Cureteq targets biotech firms and pharmaceutical companies seeking to de-risk programs at scale.